Cost and Quality

Latest KFF Health News Stories

Everyone Says We Must Control Exorbitant Drug Prices. So, Why Don’t We?

KFF Health News Original

Any momentum to address prescription drug costs has been lost amid rancorous debates over replacing Obamacare and stalled by roadblocks erected via lobbying and industry cash.

To Wage War On Superbugs, FDA Clears Way For Scope With A Disposable Piece

KFF Health News Original

Agency says a removable cap will lower the risk of antibiotic resistant infections but some experts see it as a modest step in curbing the sort of deadly outbreaks that occurred a few years ago.

Abre la boca y di “ahhh”: los dentistas tratan cada vez a niños más pequeños

KFF Health News Original

Asociaciones de odontólogos recomiendan que los niños pequeños vayan al dentista antes de cumplir el año, o cuando se asoma el primer diente, para evitar un futuro lleno de caries.

Open Your Mouth And Say Goo-Goo: Dentists Treating Ever-Younger Patients

KFF Health News Original

A shift in dental guidelines encourages first dental visits for infants as young as 6 months, or when the first baby teeth emerge. That makes some dentists uncomfortable.

Reporter’s Notebook: In Health Care, A Good Price (Or Any Price) Is Hard To Find

KFF Health News Original

Not only are health prices hidden, industry players are contractually obligated to keep them secret. That’s why answering a simple question — how much does it cost to have a baby in Mountain View, Calif.? — became a journalistic quest.

FDA Moves To Guard Against Abuse Of ‘Orphan Drug’ Program

KFF Health News Original

Following a KHN investigation, the Food and Drug Administration has moved to speed up approvals of “orphan drugs” while closing a loophole that allowed drugmakers to skip pediatric testing.

Cuestionan la necesidad de una vacuna contra la meningitis B para universitarios

KFF Health News Original

Expertos dicen que farmacéuticas están apelando al miedo de los padres para promover dos vacunas contra le meningitis B entre estudiantes universitarios, luego de dos brotes en campus.

Guess Who Pays The Price When Hospital Giants Hire Your Private Practitioner?

KFF Health News Original

Gobbling up doctors’ independent practices is lucrative for hospital systems — but not necessarily a good deal for the physicians or consumers, critics say. Northern California is a case in point.

For Low-Income Drug Users, Medi-Cal Offers A Fresh Start

KFF Health News Original

Under a five-year agreement with the federal government, California is using Medicaid dollars to expand drug treatment, including more inpatient care and a broader range of medications.

Lawmakers Debate How Much Wiggle Room To Give States In Health Care

KFF Health News Original

The federal health law includes a provision that allows states to alter some of its rules if they can think of a better way to provide health care to their residents, but it’s not clear how far outside the box states can go.

How Below-The-Radar Mergers Fuel Health Care Monopolies

KFF Health News Original

Most acquisitions by hospitals of physician practices are too small to trigger antitrust attention, study says. But a buying spree of “onesies and twosies” doctor practices has driven competition down and prices up.

Why One California County Went Surgery Shopping

KFF Health News Original

Fed up with high hospital costs and limited competition, Santa Barbara County sends willing employees out of town for better bargains. Local governments are slowly joining private employers in aggressively seeking out the best care for the lowest price. 

Trump Administration Whacks Millions From Budget Used To Push Obamacare

KFF Health News Original

The federal government plans to spend millions of dollars less this year on advertising and outreach efforts to support the health law’s open enrollment period, which starts Nov. 1.

Algunos pacientes con cáncer de tiroides pueden retrasar la cirugía

KFF Health News Original

Alrededor de un tercio de los pacientes con un tumor de tiroides de crecimiento lento, llamado cáncer de tiroides papilar, son elegibles para retrasar el tratamiento, según un nuevo estudio.